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Abstract
Background—Epidemiologic studies have shown that a large proportion of coronary heart disease
and stroke events are explained by borderline or elevated risk factors, and that adults with optimal
risk factors greatly avoid these events. The degree to which this applies to heart failure incidence is
not well documented.
Methods and Results—We categorized baseline (1987–89) risk factors in the Atherosclerosis
Risk in Communities Study cohort (n = 13,460, aged 45–64) into optimal, borderline, and elevated
groups based on national guidelines, using a 4-factor score (blood pressure, plasma cholesterol,
diabetes, and smoking) and a 5-factor score (body mass also). Incidence of hospitalized heart failure
(n =1,344) was identified over a 16-year period. Only 4.9% of the cohort at baseline had all optimal
risk factors based on the 4-factor score and 2.6% using the 5-factor score. Compared to participants
with any elevated risk factor using the 4-factor score, the age-, sex-, race-adjusted relative hazard
for heart failure events was 0.18 (95% CI 0.10–0.32) for those with all optimal risk factors and 0.35
(95% CI 0.30–0.41) for those with borderline risk factors only. A population attributable fraction
estimate suggested that having at least one of the four risk factors, elevated or borderline, accounted
for 77.1% of heart failure events. For the 5-factor score, that percentage was 88.8%.
Conclusion—Middle-aged adults with optimal (low) risk factors have low incidence rates of heart
failure, which supports redoubled efforts to prevent risk factor development in the first place.
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Much of the United States adult population is at risk of cardiovascular disease (CVD) by virtue
of having one or more traditional CVD risk factors – i.e., high blood pressure (BP), high blood
cholesterol, cigarette smoking, diabetes, and excess body weight. However, recent
epidemiologic studies by Stamler and others have emphasized the potential of primary
prevention by showing that adults with no risk factors have a quite low incidence of CVD.1–
6 We recently showed that this was true for CVD among African Americans and whites in the
Atherosclerosis Risk in Communities (ARIC) Study.7 Maintaining a life without developing
a CVD risk factor therefore should be a universal goal.
Prior studies of optimal CVD risk have generally focused on rates of coronary heart disease
(CHD), stroke, or total CVD. Heart failure is a growing public health problem8 and affects 1
in 5 U.S. adults eventually.9 Although heart failure has several risk factors in common with
CHD, and is often a result of CHD, no study has documented the degree to which adults with
optimal risk factors avoid heart failure. To examine this issue, we calculated the absolute and
attributable risks of heart failure incidence in relation to optimal risk factor levels in the ARIC
study. In addition, we performed risk estimates for CHD and stroke separately, as our previous
paper pooled these outcomes.
Methods
Study Design and Subjects
The ARIC Study is a prospective cohort study of atherosclerotic diseases in four US
communities: Forsyth County, North Carolina; Jackson, Mississippi; Washington County,
Maryland; and the northwest suburbs of Minneapolis, Minnesota.10 The cohort comprised, at
baseline in 1987–89, 15,792 men and women aged 45 to 64 years who were selected by list or
area probability sampling. Only African Americans were recruited in the Jackson study center.
The baseline home interview and clinic examination measured various risk factors and
cardiovascular conditions. The ARIC Study protocol was approved by the institutional review
board of each participating university.
Baseline Examination
Sitting BP was measured three times using a random-zero sphygmomanometer after five
minutes rest.11 The mean of the last two measurements was used for analysis. Use of
antihypertensive medications within the past two weeks of baseline interview was self-
reported.12 Fasting plasma total cholesterol was measured by enzymatic methods.13 Serum
glucose was measured by a hexokinase/glucose-6-phosphate dehydrogenase method. Smoking
status (current, former, or never smokers) was derived from interviews. Body mass index (BMI,
kg/m2) was computed from weight in a scrub suit and standing height. Pre-existing heart failure
at baseline was defined as: (1) an affirmative response to “Were any of the medications you
took during the last 2 weeks for heart failure?” or (2) Stage 3 or “manifest heart failure” by
Gothenburg criteria.14,15 Pre-existing coronary heart disease (CHD) at baseline was defined
by self-reported prior physician diagnosis of myocardial infarction (MI) or coronary
revascularization, or by prevalent MI by 12 lead electrocardiogram.16 Pre-existing stroke was
defined by any self-reported prior physician diagnosis of stroke.
Risk Factor Classification
We created two baseline risk factor scores for analysis. The 4-factor score, which we used
previously,7 was based on blood pressure, total cholesterol, diabetes, and smoking. The 5-factor
score additionally included body mass. We first classified CVD risk factors into optimal (low),
borderline, or elevated categories according to national guidelines (Table 1).17–20 In this paper,
we added impaired fasting glucose (100–125 mg/dL) as a borderline category. Since, in
observational studies, participants under medical treatment typically have higher CVD risk
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than subjects with borderline risk, we included treated participants in the elevated category.
We then summed the number of risk factors to create the 4-factor and 5-factor risk scores. Our
main presentation is based on the 4-factor score, but we also mention findings for the 5-factor
score.
Incident and Fatal Events
We followed all participants from the baseline examination in 1987–89 to the date of CVD
event, death, loss to follow-up, or else through December 31, 2005 (heart failure and CHD) or
December 31, 2004 (stroke). CVD events in ARIC were ascertained by contacting participants
annually, identifying hospitalizations and deaths during the prior year, and by surveying
discharge lists from local hospitals and death certificates from state vital statistics offices for
potential CVD events.12,21,22 Incident heart failure in ARIC was defined as the first occurrence
of either: 1) a hospitalization which included an International Classification of Diseases, 9th
revision (ICD-9) discharge code of ‘428’ (428.0–428.9) among the primary or secondary
diagnoses or else 2) a death certificate with an ICD-9 code of ‘428’ or an ICD-10 code of ‘I50’
among the listed or underlying causes of death.15
For patients hospitalized with a potential MI, trained abstractors recorded the presenting
symptoms and related clinical information, including cardiac enzymes, and photocopied up to
three 12-lead ECGs for Minnesota coding.16,23 Out-of-hospital deaths were investigated by
means of death certificates and, in most cases, by an interview with one or more next of kin
and a questionnaire filled out by the patient’s physician. Coroner reports or autopsy reports,
when available, were abstracted for use in validation. A CHD event was defined as a validated
definite or probable hospitalized MI or a definite CHD death. The criteria for definite or
probable MI were based on combinations of chest pain symptoms, ECG changes, and cardiac
enzyme levels.21,22 The criteria for definite fatal CHD were based on chest pain symptoms,
history of CHD, underlying cause of death from the death certificate, and any other associated
hospital information or medical history, including that from an ARIC clinic visit.21 22
The diagnostic classification of stroke was described previously.24 In brief, for potential
hospitalized strokes, the abstractors recorded signs and symptoms and photocopied
neuroimaging (CT or MRI) and other diagnostic reports. Using criteria adopted from the
National Survey of Stroke,25 strokes were classified by computer algorithm and separate
review by a physician, with disagreements resolved by a second physician.
Statistical Analyses
Of 15,792 ARIC participants at baseline, we excluded, due to small numbers, participants who
were neither white nor African American subjects (n=48). We further excluded 1,971 who had
a history of heart failure, CHD or stroke, or could not be classified on history. Subjects (n=313)
who did not have complete information on plasma cholesterol, cigarette smoking, BP value,
or serum glucose were also excluded. In all, 13,460 participants were included in the analysis
for the 4-factor score and slightly fewer (n = 13,453) for the 5-factor score.
Crude incidence rates were calculated separately for each endpoint (heart failure, CHD, or
stroke) according to risk factor groups. Persons with multiple endpoints were included with
all individual endpoints. Follow-up time went from baseline until the first of: (1) incident
endpoint, (2) lost to follow-up, (3) death, or (4) cessation of follow-up. The relative hazards
(RH) of incident of heart failure (or CHD or stroke) in relation to risk factor groups were
estimated from Cox proportional hazard models adjusted for age, sex, and sometimes race. We
treated the participants with at least one elevated risk factor as the reference group. The
population attributable fraction (PAF) was calculated as p times [(RH for risk factor category
being considered-RH for the optimal risk category)/RH for risk factor category being
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considered], where p = proportion of cases that are exposed in whichever risk factor category
is being considered.26 In a supplemental analysis, we stratified the heart failure endpoint on
whether it occurred after an interim myocardial infarction or coronary revascularization
(“ischemic”) or with no such history (“non-ischemic”), and calculated the PAFs for each heart
failure stratum relative to those who did not develop heart failure.
The authors had full access to the data and take responsibility for its integrity. All authors have
read and agree to the manuscript as written.
Results
Prevalence of Risk Categories
As shown in Table 1, the ARIC Study cohort in 1987–89 had a baseline mean age of 53.9 years.
Higher proportions of African Americans than whites had hypertension (53.8% versus 27.9%),
diabetes (17.5% versus 8.0%), and obesity (39.3% versus 21.6%). However, more African
Americans than whites had an optimal cholesterol level (40.4% versus 36.8%) and had never
smoked (47.3% versus 41.4%). As shown in Table 2, based on the 4-factor score involving
blood pressure, cholesterol, diabetes, and smoking, only 4.9% of the cohort had all optimal
risk factors (3.0% in African Americans and 5.6% in whites). On the other hand, 78.5% of
African Americans had at least one of the four risk factors elevated, compared with 60.6% of
whites. When we instead used the 5-factor score that included BMI, only 2.6% of the cohort
had all optimal risk factors (1.0% in African Americans and 3.2% in whites), and 85.5% of
African Americans and 67.1% of whites had at least one elevated risk factor.
Heart Failure Incidence
The mean duration of follow-up was 15.7 years (maximum, 19 years) during which 1,344
incident heart failure events occurred. Compared to participants with any elevated risk factor
using the 4-factor score, the age-, sex-, and race-adjusted RH for heart failure events was 0.18
(95% CI 0.10–0.32) for those with all optimal risk factors (n = 12 events among 665
participants) and 0.35 (95% CI 0.30–0.41) for those with borderline risk factors only (Table
3). These RHs were 0.28 and 0.31, respectively, in African Americans and 0.16 and 0.36 in
whites. The PAF estimate suggested that having at least one elevated risk factor in the 4-factor
score accounted for 70.6% of heart failure events; borderline risk factors accounted for just
6.5% more. Thus, elevated and borderline levels of the 4 risk factors, together, seemed to
account for a majority heart failure events in African Americans (67.5%) and whites (79.1%).
When we instead computed risks using the 5-factor score (also with BMI), the low prevalence
of having only optimal risk factors meant that only 3 heart failure events occurred in whites
with optimal risk factors, and 0 in African Americans. The PAF estimates suggested that
elevated and borderline levels of the 5 factors accounted for 88.8% of heart failure events
overall –100% in African Americans and 85.8% in whites.
Overall, 30% of participants who developed clear “ischemic” heart failure, that is, they had a
definite or probable myocardial infarction or coronary revascularization between ARIC
baseline and the first heart failure event. This percentage with an interim CHD event was 8%
in those with all optimal risk factors, 27% in those with only borderline risk factors, and 31%
in those having any elevated risk factor, based on the 4-factor score. The PAF of having non-
optimal levels of the 4 factors was 94.2% for “ischemic” heart failure (i.e., after interim CHD)
and 69.6% for “non-ischemic” heart failure (i.e., no interim CHD).
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CHD and Stroke Incidence
We previously reported the PAF of CVD (CHD plus stroke) for elevated or borderline risk
factors using the 4-factor score was 76.4% in ARIC over 13 years.7 We have now recalculated
these PAFs for CHD and stroke, separately, over 15 to 16 years. Among African Americans,
the PAFs were 100% for CHD events (Table 4) and 85.8% for strokes (Table 5). Among whites,
these values were 75.0% and 59.9%, respectively.
If instead we used the 5-factor score, among African Americans the PAFs were 100% for CHD
and 55.5% for strokes, and among whites were 76.9% for CHD and 75.9% for strokes.
Discussion
The main findings of this study of middle-aged adults recruited in the late 1980s and followed
an average of 15 years were that (1) incidence of heart failure, especially “ischemic” heart
failure, seemed explained to large degree (77% or more) by traditional CVD risk factors and
(2) the few subjects with optimal risk factors rarely developed heart failure. This was true for
both African Americans and whites. Previous studies, for example, the Framingham Heart
Study8,9,27 have documented the absolute and relative risks of heart failure in relation to
traditional risk factors. Lifetime risk of heart failure in Framingham was 20%.9 Hypertension
was a key risk factor; PAFs suggested it accounted for 39% of heart failure events in
Framingham men and 59% in women.28 Previous studies have also demonstrated that subjects
with a favorable CVD risk profile rarely develop CHD and/or stroke.1–7 Others have reported
that those with CVD-healthy behaviors also are at very low CVD risk.29,30 However, our report
seems to be the first to show that approximately 77% of heart failure events in middle-aged
adults might also be prevented with the avoidance of risk factors. It therefore further
emphasizes the need for preventing the development of risk factors in the first place, in addition
to other recommended strategies for the primary and secondary prevention of heart failure.31
The prevalence of an optimal risk factor profile in this sample, and in previous reports, was
very low. Only 3.0% of these middle-aged African Americans and 5.6% of whites had optimal
levels of blood pressure, plasma cholesterol, and serum glucose, and had never smoked. Only
1.0% and 3.2%, respectively, had optimal risk factors if BMI was also included in the profile.
The lower prevalence of optimal risk factors in African Americans than whites was also
reported by the Multiple Risk Factor Intervention Study4 and Third National Health and
Nutrition Examination Survey.32 Although the prevalences of several risk factors have declined
in recent years in the U.S., prevalences of diabetes and obesity are rising, and the ethnic pattern
remains. Meanwhile, CHD and stroke mortality are declining in the U.S., but heart failure
hospitalizations and health care costs are increasing. Clearly, population and individual
approaches to CVD risk factor prevention need to remain a priority.
Study Strengths and Limitations
The strengths of this study include the careful assessment of CVD risk factors and
cardiovascular incidence for an extended follow-up period. One limitation is that heart failure
incidence, which was based on unvalidated hospital discharge and death certificate codes for
heart failure, did not include outpatient events. However, heart failure hospital discharge codes
have moderately good sensitivity and specificity.33,34 Moreover, surveillance of Rochester,
MN, indicates that 74% of heart failure cases identified in the outpatient setting are hospitalized
within 1.7 years.33 A second limitation is that we could not differentiate between systolic and
diastolic heart failure. A third limitation is that our classification into ischemic and non-
ischemic heart failure was based only on interim occurrences of myocardial infarction or
coronary revascularization. A fourth limitation is that few events occurred in the optimal risk
factor group, leading to imprecision in the heart failure incidence rate. However, this is the
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crux of our findings – that people with no risk factors rarely develop heart failure or other CVD
events.
The use of PAF values also has strengths and limitations. The PAF offers an estimate on a
population-wide basis of the proportion of cases that may be due to risk factors. It is best used
when the risk factors being considered are causally related to the disease endpoint. This is
believed to be the case for major cardiovascular risk factors. The PAF offers an estimate of the
health potential of maintaining optimal risk factors life-long, but, of course, is idealistic because
few Americans at present are able to do this.
Conclusions
Our data indicate that middle-aged adults with optimal (low) risk factor levels have low
incidence rates of heart failure, in addition to their low rates of CHD and stroke. Efforts need
to continue not only for primary prevention of CVD, but also for “primordial” prevention of
CVD risk factors in the first place.
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